Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia
Clinical trial NCT00573378 · TERMINATED
Trial details
- NCT number
- NCT00573378
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.